BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 11985964)

  • 1. Type 1, P and S fimbriae, and afimbrial adhesin I are not essential for uropathogenic Escherichia coli to adhere to and invade bladder epithelial cells.
    Miyazaki J; Ba-Thein W; Kumao T; Obata Yasuoka M; Akaza H; Hayshi H
    FEMS Immunol Med Microbiol; 2002 Mar; 33(1):23-6. PubMed ID: 11985964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Covert operations of uropathogenic Escherichia coli within the urinary tract.
    Bower JM; Eto DS; Mulvey MA
    Traffic; 2005 Jan; 6(1):18-31. PubMed ID: 15569242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fimbrial profiles predict virulence of uropathogenic Escherichia coli strains: contribution of ygi and yad fimbriae.
    Spurbeck RR; Stapleton AE; Johnson JR; Walk ST; Hooton TM; Mobley HL
    Infect Immun; 2011 Dec; 79(12):4753-63. PubMed ID: 21911462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of the Escherichia coli common pilus by uropathogenic E. coli is associated with adherence to HeLa and HTB-4 cells and invasion of mouse bladder urothelium.
    Saldaña Z; De la Cruz MA; Carrillo-Casas EM; Durán L; Zhang Y; Hernández-Castro R; Puente JL; Daaka Y; Girón JA
    PLoS One; 2014; 9(7):e101200. PubMed ID: 25036370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the NLRP3 Inflammasome Pathway by Uropathogenic
    Demirel I; Persson A; Brauner A; Särndahl E; Kruse R; Persson K
    Front Cell Infect Microbiol; 2018; 8():81. PubMed ID: 29662840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative proteomics of uropathogenic Escherichia coli during growth in human urine identify UCA-like (UCL) fimbriae as an adherence factor involved in biofilm formation and binding to uroepithelial cells.
    Wurpel DJ; Totsika M; Allsopp LP; Webb RI; Moriel DG; Schembri MA
    J Proteomics; 2016 Jan; 131():177-189. PubMed ID: 26546558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maturation of intracellular Escherichia coli communities requires SurA.
    Justice SS; Lauer SR; Hultgren SJ; Hunstad DA
    Infect Immun; 2006 Aug; 74(8):4793-800. PubMed ID: 16861667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycolipid receptors of F1C fimbrial adhesin of uropathogenic Escherichia coli.
    Khan AS; Hacker J
    Adv Exp Med Biol; 2000; 485():213-7. PubMed ID: 11109108
    [No Abstract]   [Full Text] [Related]  

  • 9. Sialic acid and N-acetylglucosamine Regulate type 1 Fimbriae Synthesis.
    Blomfield IC
    Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial invasion augments epithelial cytokine responses to Escherichia coli through a lipopolysaccharide-dependent mechanism.
    Schilling JD; Mulvey MA; Vincent CD; Lorenz RG; Hultgren SJ
    J Immunol; 2001 Jan; 166(2):1148-55. PubMed ID: 11145696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urovirulence determinants in Escherichia coli isolates causing first-episode and recurrent cystitis in women.
    Stapleton A; Moseley S; Stamm WE
    J Infect Dis; 1991 Apr; 163(4):773-9. PubMed ID: 1672702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Escherichia coli bind to urinary bladder epithelium through nonspecific sialic acid mediated adherence.
    Sakarya S; Ertem GT; Oncu S; Kocak I; Erol N; Oncu S
    FEMS Immunol Med Microbiol; 2003 Oct; 39(1):45-50. PubMed ID: 14556995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo adherence of uropathogenic Escherichia coli strains.
    Hopkins WJ; Jensen JL; Uehling DT; Balish E
    J Urol; 1986 Jun; 135(6):1319-21. PubMed ID: 2872339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localization of a domain in the FimH adhesin of Escherichia coli type 1 fimbriae capable of receptor recognition and use of a domain-specific antibody to confer protection against experimental urinary tract infection.
    Thankavel K; Madison B; Ikeda T; Malaviya R; Shah AH; Arumugam PM; Abraham SN
    J Clin Invest; 1997 Sep; 100(5):1123-36. PubMed ID: 9276729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The PapG-adhesin at the tip of P-fimbriae provides Escherichia coli with a competitive edge in experimental bladder infections of cynomolgus monkeys.
    Winberg J; Möllby R; Bergström J; Karlsson KA; Leonardsson I; Milh MA; Teneberg S; Haslam D; Marklund BI; Normark S
    J Exp Med; 1995 Dec; 182(6):1695-702. PubMed ID: 7500014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular epidemiology of adhesin and hemolysin virulence factors among uropathogenic Escherichia coli.
    Arthur M; Johnson CE; Rubin RH; Arbeit RD; Campanelli C; Kim C; Steinbach S; Agarwal M; Wilkinson R; Goldstein R
    Infect Immun; 1989 Feb; 57(2):303-13. PubMed ID: 2563254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrin-mediated host cell invasion by type 1-piliated uropathogenic Escherichia coli.
    Eto DS; Jones TA; Sundsbak JL; Mulvey MA
    PLoS Pathog; 2007 Jul; 3(7):e100. PubMed ID: 17630833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isogenic P-fimbrial deletion mutants of pyelonephritogenic Escherichia coli: the role of alpha Gal(1-4) beta Gal binding in virulence of a wild-type strain.
    Mobley HL; Jarvis KG; Elwood JP; Whittle DI; Lockatell CV; Russell RG; Johnson DE; Donnenberg MS; Warren JW
    Mol Microbiol; 1993 Oct; 10(1):143-55. PubMed ID: 7968511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uropathogenic Escherichia coli Express Type 1 Fimbriae Only in Surface Adherent Populations Under Physiological Growth Conditions.
    Stærk K; Khandige S; Kolmos HJ; Møller-Jensen J; Andersen TE
    J Infect Dis; 2016 Feb; 213(3):386-94. PubMed ID: 26290608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type 1 pilus-mediated bacterial invasion of bladder epithelial cells.
    Martinez JJ; Mulvey MA; Schilling JD; Pinkner JS; Hultgren SJ
    EMBO J; 2000 Jun; 19(12):2803-12. PubMed ID: 10856226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.